Sandoz general medication

Sandoz is a global leader in generic and biosimilar pharmaceuticals. The brand was originally established in Switzerland in 1886 and has a long history as part of the Swiss chemical and pharmaceutical industry. For many years, Sandoz operated as a key division within the Novartis Group.

Following a strategic spin-off categorized for completion in late 2023, Sandoz became an independent, publicly traded company. Its products are manufactured across a global network of facilities, primarily in Europe (including Austria, Germany, and Slovenia), to ensure widespread access to affordable medicine. The company remains headquartered in Switzerland, continuing its legacy of Swiss precision in the healthcare sector.